Finance

Senarai
524804:BOM
Aurobindo Pharma Ltd
₹1,683.00
-1.16%
(-19.75) 1H
13 Okt, 3:30:00 PTG GMT+5:30  ·   INR
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 524804...
Buka
₹1,708.50
Tinggi
₹1,708.50
Rendah
₹1,665.10
Permodalan Pasaran
969.28B
Purata volum
25.95K
Volum
47.02K
Nisbah H/P
26.30
tgi 52 mgu
₹1,739.95
rdh 52 mgu
₹1,080.10
EPS
₹64.00
Syer tertunggak
585.90J
Bilangan pekerja
29K
Buka
₹1,708.50
Tinggi
₹1,708.50
Rendah
₹1,665.10
Permodalan Pasaran
969.28B
Purata volum
25.95K
Volum
47.02K
Nisbah H/P
26.30
tgi 52 mgu
₹1,739.95
rdh 52 mgu
₹1,080.10
EPS
₹64.00
Syer tertunggak
585.90J
Bilangan pekerja
29K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
Perihal Aurobindo Pharma Ltd
CEO-
Pekerja29.2K
Diasaskan1986
Ibu pejabatHyderabad, Andhra Pradesh, India
Sektor-
Laman webaurobindo.com
Laporan sebelumnyaSemua nilai dalam INR
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam INR
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
82.86B
86.46B
88.53B
91.50B
Kos barangan yang dijual
33.39B
34.81B
39.28B
36.27B
Kos hasil
33.39B
34.81B
39.28B
36.27B
Perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
12.77B
13.10B
14.31B
14.80B
Belanja kendalian
36.98B
38.56B
35.29B
41.29B
Jumlah belanja kendalian
70.37B
73.37B
74.57B
77.56B
Pendapatan kendalian
12.49B
13.09B
13.96B
13.94B
Pendapatan bukan kendalian lain
1.16B
1.54B
-2.51B
2.12B
EBT termasuk item luar biasa
12.76B
13.39B
12.91B
15.15B
EBT tidak termasuk item luar biasa
12.76B
14.04B
13.59B
15.55B
Belanja cukai pendapatan
4.28B
4.29B
3.70B
4.83B
Kadar cukai berkesan
33.53%
32.03%
28.65%
31.88%
Belanja kendalian lain
19.91B
20.81B
16.37B
21.62B
Pendapatan bersih
8.48B
9.10B
9.21B
10.33B
Margin untung bersih
10.24%
10.53%
10.41%
11.28%
Perolehan bagi setiap syer
14.61
16.43
15.86
17.46
Pendapatan faedah dan pelaburan
-
-
3.31B
-
Belanja faedah
-952.40J
-927.70J
-665.50J
-1.02B
Belanja faedah bersih
-952.40J
-927.70J
2.65B
-1.02B
Caj susut nilai dan pelunasan
4.29B
4.65B
4.61B
4.87B
EBITDA
16.66B
16.71B
18.03B
18.01B
Keuntungan atau kerugian daripada jualan aset
-
-
-
-
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google